Recent Progress in the Development of Selective MAGL Modulators (2020-2026)

Eva Landucci1,2, Chiara Lonzi1, Tommaso Bonomo1

  • 1Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.

Summary

Selective modulators of Monoacylglycerol lipase (MAGL) are crucial for targeting inflammation, pain, and neurodegeneration. Recent advances have expanded the chemical space of MAGL inhibitors and alternative strategies for therapeutic development.